Antinuclear Antibody (ANA) Testing in Patients Treated With Biological DMARDs: Is It Useful?
Crossref DOI link: https://doi.org/10.1007/s11926-015-0500-9
Published Online: 2015-04-09
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
García-De LaTorre, Ignacio
García-Valladares, Ignacio
Text and Data Mining valid from 2015-04-01